The novel treatment of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide774360.develop-blog.com/49945757/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment